{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:32:50Z","timestamp":1789389170637,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4810,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1046\/j.1523-1747.2002.00217.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:04:22Z","timestamp":1047449062000},"page":"783-792","source":"Crossref","is-referenced-by-count":63,"title":["Pathways to Melanoma Development: Lessons from the Mouse"],"prefix":"10.1016","volume":"119","author":[{"given":"Graeme J.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/scbi.2000.0342","article-title":"Cellular transformation by SV40 large T antigen: interaction with host proteins","volume":"11","author":"Ali","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0015","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1128\/MCB.17.7.3850","article-title":"Ras links factor signalling to the cell cycle machinery via regulation of cyclin D1 and Cdk inhibitor p27","volume":"17","author":"Atkas","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0020","first-page":"2298","article-title":"Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors","volume":"58","author":"Bahuau","year":"1998","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0025","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/MCB.21.6.2144-2153.2001","article-title":"Dual inactivation of RB and p53 pathways in RAS-induced melanomas","volume":"21","author":"Bardeesy","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/25867","article-title":"p14ARF links the tumour suppressors RB and p53","volume":"395","author":"Bates","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0749.1999.tb00746.x","article-title":"Transgenic models for tumors of melanocytes and retinal pigment epithelium","volume":"12","author":"Beermann","year":"1999","journal-title":"Pigment Cell Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1073\/pnas.88.1.164","article-title":"Malignant melanoma in transgenic mice","volume":"88","author":"Bradl","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/mc.2940120205","article-title":"Hyperpigmentation and melanocytic dysplasia in transgenic mice expressing human T24 Hras gene regulated by a mouse tyrosinase promoter","volume":"12","author":"Broome Powell","year":"1995","journal-title":"Mol Carcinogen"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0050","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/carcin\/20.9.1747","article-title":"Induction of melanoma in TPras transgenic mice","volume":"20","author":"Broome-Powell","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0055","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/35004020","article-title":"p16INK4A and p19ARF act in overlapping pathways in cellular immortalisation","volume":"2","author":"Carnero","year":"2000","journal-title":"Nature Cell Biol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0065","first-page":"4868","article-title":"CDKN2A\/p16 is inactivated in most melanoma cell lines","volume":"57","author":"Castellano","year":"1997","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0070","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/1523-1747.ep12340194","article-title":"Spontaneous melanocytosis in transgenic mice","volume":"106","author":"Chen","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0075","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1101\/gad.11.21.2822","article-title":"Cooperative effects of INK4a and ras in melanoma susceptibility in vivo","volume":"11","author":"Chin","year":"1997","journal-title":"Genes Dev"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0968-0004(98)01236-5","article-title":"The INK4a\/ARF tumor suppressor: one gene-two products-two pathways","volume":"23","author":"Chin","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/22788","article-title":"Essential role for oncogenic Ras in tumour maintenance","volume":"400","author":"Chin","year":"2000","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/1235","article-title":"Pten is essential for embryonic development and tumour suppression","volume":"19","author":"Di Cristofano","year":"1998","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/84879","article-title":"Pten and p27Kip1 cooperate in prostate cancer tumor suppression in mouse","volume":"27","author":"Di Cristofano","year":"2001","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-8628(19981002)79:4<284::AID-AJMG10>3.0.CO;2-N","article-title":"Inherited macrocephaly\u2013hamartoma syndromes","volume":"79","author":"DiLiberti","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0105","first-page":"115","article-title":"CDKN2A mutations in melanoma","volume":"26","author":"Dracopoli","year":"1996","journal-title":"Cancer Surveys"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00008390-200010000-00001","article-title":"Protein tyrosine kinases in malignant melanoma","volume":"10","author":"Easty","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0115","first-page":"883","article-title":"N-ras oncogene point mutations induced by sun exposure in primary cutaneous melanoma","volume":"149","author":"van Elsas","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0749.1993.tb00611.x","article-title":"From the crest to the periphery. control of pigment cell migration and lineage segregation","volume":"6","author":"Erickson","year":"1993","journal-title":"Pigment Cell Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0125","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.onc.1204220","article-title":"Human ARF binds E2F1 and inhibits its transcriptional activity","volume":"20","author":"Eymin","year":"2001","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0130","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1101\/gad.12.18.2899","article-title":"CDK inhibitors p18INK4C and p27KIP1 mediate two sperate pathways to collaboratively suppress pituitary tumorigenesis","volume":"12","author":"Franklin","year":"1998","journal-title":"Genes Dev"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1523-1747.ep12263512","article-title":"Characterization and histogenesis of tumors in the hairless mouse produced by low-dosage incremental ultraviolet radiation","volume":"83","author":"Gallagher","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0140","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/j.1460-2075.1994.tb06607.x","article-title":"A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice","volume":"13","author":"Ganss","year":"1994","journal-title":"EMBO J"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0145","first-page":"5804","article-title":"CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cells lines","volume":"54","author":"He","year":"1994","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0150","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/34681","article-title":"MAP kinase links the transcription factor microphthalmia to c-kit signalling in melanocytes","volume":"391","author":"Hemesath","year":"1998","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0155","first-page":"223","article-title":"Structure and function of melanocytes: Microscopic morphology and cell biology of mouse melanocytes in the epidermis and hair follicle","volume":"10","author":"Hirobe","year":"1995","journal-title":"Histol Histopathol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0160","first-page":"1021","article-title":"Heterozygous Rb-1 delta 20\/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance","volume":"4","author":"Hu","year":"1994","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0165","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1074\/jbc.274.6.3396","article-title":"RhoA stimulates p27 (Kip) degradation through its regulation of cyclin E\/CDK2 activity","volume":"274","author":"Hu","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0092-8674(00)81872-3","article-title":"Oncoprotein networks","volume":"88","author":"Hunter","year":"1997","journal-title":"Cell"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0180","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/j.1460-2075.1991.tb04878.x","article-title":"Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein\/ret fusion gene","volume":"10","author":"Iwamoto","year":"1991","journal-title":"EMBO J"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/359295a0","article-title":"Effects of an Rb mutation in the mouse","volume":"359","author":"Jacks","year":"1992","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumour suppression at the mouse INK4a locus mediated by the alternate reading frame product p19ARF","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0200","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.onc.1202077","article-title":"Transgenic mouse model for skin malignant melanoma","volume":"17","author":"Kato","year":"1998","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0205","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1523-1747.2000.0202a-2.x","article-title":"Ultraviolet radiation induces both full activation of ret kinase and malignant melanocytic tumor promotion in RFP-RET-transgenic mice","volume":"115","author":"Kato","year":"2000","journal-title":"Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0210","first-page":"4061","article-title":"Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility","volume":"58","author":"Kelsall","year":"1998","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1073\/pnas.88.1.169","article-title":"Melanosis and associated tumors in transgenic mice","volume":"88","author":"Klein-Szanto","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0220","first-page":"4569","article-title":"Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice","volume":"54","author":"Klein-Szanto","year":"1994","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/35092584","article-title":"Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice","volume":"413","author":"Krimpenfort","year":"2001","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1098-2264(199811)23:3<273::AID-GCC11>3.0.CO;2-N","article-title":"Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines","volume":"23","author":"Kumar","year":"1998","journal-title":"Genes Chrom Cancer"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0235","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.187.10.1565","article-title":"Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor","volume":"187","author":"Kunisada","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0240","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood.V91.4.1101","article-title":"c-kit ligand and Flt3 ligand: stem\/progenitor cell factors with overlapping yet distinct activities","volume":"91","author":"Lyman","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0962-8924(99)01519-6","article-title":"PTEN: a tumour suppressor that functions as a phospholipid phosphatase","volume":"9","author":"Maehama","year":"1999","journal-title":"Trends Cell Biol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0250","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.90.19.8817","article-title":"Transgenic mouse model of malignant skin melanoma","volume":"90","author":"Mintz","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0255","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1128\/MCB.19.5.3916","article-title":"Induction of p21 (WAF1\/CIP1) and inhibition of Cdk2 mediated by tumor suppressor p16 (INK4A)","volume":"19","author":"Mitra","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0260","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"336","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0265","first-page":"3738","article-title":"Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor\/scatter factor transgenic mice","volume":"60","author":"Noonan","year":"2000","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/35095108","article-title":"Neonatal sunburn and melanoma in mice","volume":"413","author":"Noonan","year":"2001","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0275","first-page":"5157","article-title":"c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype","volume":"58","author":"Otsuka","year":"1998","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0280","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1038\/sj.onc.1203151","article-title":"PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein","volume":"18","author":"Paramio","year":"1999","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0285","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/sj.onc.1202196","article-title":"Tumors of the retinal pigment epithelium metastasise to the inguinal lymph nodes and spleen in tyrosinase-related protein 1\/SV40 T antigen transgenic mice","volume":"17","author":"Penna","year":"1998","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0290","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/gcc.1159","article-title":"CDKN2A germline splicing mutation affecting both p16 (ink4) and p14 (arf) RNA processing in a melanoma\/neurofibroma kindred","volume":"31","author":"Petronzelli","year":"2001","journal-title":"Genes Chromosom Cancer"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<13::AID-IJC3>3.0.CO;2-#","article-title":"Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study","volume":"78","author":"Platz","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0300","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1073\/pnas.96.4.1563","article-title":"Mutations of Pten\/Mmac1 in mice causes neoplasia in multiple organ systems","volume":"96","author":"Podsypanina","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0305","first-page":"667","article-title":"The, genetics, of, cutaneous, melanoma","volume":"20","author":"Pollock","year":"2000","journal-title":"Clin Lab Med"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0310","series-title":"Melanoma Res","article-title":"PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines","author":"Pollock","year":"2002"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0315","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1523-1747.ep12521335","article-title":"Developmental biology of mammalian melanocytes","volume":"75","author":"Quevedo","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/hmg\/10.1.55","article-title":"A germline deletion of p14 (ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family","volume":"10","author":"Randerson-Moor","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0325","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/8751","article-title":"Loss of CDK4 expression causes insulin-deficient diabetes and CDK4 activation results in b-islet cell hyperplasia","volume":"22","author":"Rane","year":"1999","journal-title":"Nature Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0330","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.onc.1205150","article-title":"Hepatocyte growth factor\/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1","volume":"21","author":"Recio","year":"2002","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0335","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1038\/sj.onc.1204728","article-title":"A melanoma-associated germline mutation in exon 1b inactivates p14ARF","volume":"20","author":"Rizos","year":"2001","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0340","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<600::AID-IJC19>3.0.CO;2-2","article-title":"Ectopic expression of ret results in microphthalmia and tumors of the retinal pigment epithelium","volume":"80","author":"Schmidt","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0345","first-page":"6321","article-title":"CDKN2 (p16\/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas","volume":"54","author":"Schmidt","year":"1994","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0350","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0355","doi-asserted-by":"crossref","first-page":"11617","DOI":"10.1074\/jbc.R100063200","article-title":"Signalling networks that link cell proliferation and cell fate","volume":"277","author":"Sears","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0360","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of INK4a locus in tumour suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0365","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35092592","article-title":"Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis","volume":"413","author":"Sharpless","year":"2001","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0370","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors. positive and negative regulators of G1-S phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0375","first-page":"630","article-title":"Differences in latency and inducibility of mouse skin melanomas depending on the age and anatomic site of the skin","volume":"58","author":"Silvers","year":"1998","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0380","first-page":"6637","article-title":"Wide spectrum of tumours in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors","volume":"20","author":"Sotillo","year":"2001","journal-title":"EBMO J"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0385","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1073\/pnas.241338598","article-title":"Invasive melanoma in Cdk4-targeted mice","volume":"98","author":"Sotillo","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0390","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1046\/j.1523-1747.2002.00217.x_bb0395","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jnci\/94.6.446","article-title":"p16 (Ink4a) in melanocyte senescence and differantiation","volume":"94","author":"Sviderskaya","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1046\/j.1523-1747.2002.00217.x_bb0400","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1600-0749.1992.tb00560.x","article-title":"Proliferation and neoplastic transformation of pigment cells in metallothionein\/ret transgenic mice","volume":"5","author":"Takahashi","year":"1992","journal-title":"Pigment Cell Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0405","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1073\/pnas.93.12.5866","article-title":"Scatter factor\/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development","volume":"93","author":"Takayama","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0410","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00008390-199904000-00006","article-title":"Expression of cell cycle regulators in human cutaneous malignant melanoma","volume":"9","author":"Tang","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0415","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.onc.1203331","article-title":"Inhibition of H-Ras transformation by the PTEN\/MMAC1\/TEP1 tumor suppressor gene","volume":"19","author":"Tolkacheva","year":"2000","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0420","first-page":"109","article-title":"Novel mutations in the p16\/CDKN2A binding region of the cyclin dependent kinase-4 gene","volume":"58","author":"Tsao","year":"1998","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0425","first-page":"1800","article-title":"Relative reciprocity of NRAS and PTEN\/MMAC1 alterations in cutaneous melanoma cell lines","volume":"60","author":"Tsao","year":"2000","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0430","first-page":"883","article-title":"Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary cutaneous melanoma","volume":"149","author":"Van Elsas","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0435","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-642-46870-4_18","article-title":"Signal transduction by the receptor tyrosine kinase Ret","volume":"154","author":"Van Weering","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0440","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N","article-title":"Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets","volume":"22","author":"Walker","year":"1998","journal-title":"Genes Chrom Cancer"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0445","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00008390-200108000-00004","article-title":"No evidence of a role for activating CDK2 mutations in melanoma","volume":"11","author":"Walker","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0450","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0749.1997.tb00463.x","article-title":"Signal transduction by melanoma oncogenic receptor tyrosine kinase Xmrk in melanoma formation of Xiphophorus","volume":"10","author":"Wellbrock","year":"1997","journal-title":"Pigment Cell Res"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0455","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/hmg\/10.6.599","article-title":"PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model","volume":"10","author":"Weng","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1023\/A:1008980919928","article-title":"Childhood sun exposure as a risk factor for melanoma. A systematic review of epidemiological studies","volume":"12","author":"Whiteman","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0465","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/375694a0","article-title":"Interactions between the retinoblastoma protein and the oncoprotein mdm2","volume":"375","author":"Xiao","year":"1995","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0470","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1073\/pnas.022632099","article-title":"Genetic analysis of Pten and Ink4a\/Arf interactions in the suppression of tumorigenesis in mice","volume":"99","author":"You","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0475","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","article-title":"ARF promotes mdm2 degradation and stabilizes p53; ARF-INK4a locus deletion impairs both Rb and p53 tumour suppression pathways","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0480","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1523-1747.1998.00133.x","article-title":"Development of heritable melanoma in transgenic mice","volume":"110","author":"Zhu","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2002.00217.x_bb0485","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations of the p16 binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15300294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15300294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T21:20:27Z","timestamp":1584480027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15300294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0022202X15300294"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2002.00217.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}